121 related articles for article (PubMed ID: 11495695)
1. K(+)-p-nitrophenylphosphatase inhibition by neurotensin involves high affinity neurotensin receptor: influence of potassium concentration and enzyme phosphorylation.
López Ordieres MG; Rodríguez de Lores Arnaiz G
Regul Pept; 2001 Sep; 101(1-3):183-7. PubMed ID: 11495695
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of neurotensin-stimulated mast cell secretion and carboxypeptidase A activity by the peptide inhibitor of carboxypeptidase A and neurotensin-receptor antagonist SR 48692.
Miller LA; Cochrane DE; Feldberg RS; Carraway RE
Int Arch Allergy Immunol; 1998 Jun; 116(2):147-53. PubMed ID: 9652308
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin inhibits neuronal Na+,K+-ATPase activity through high affinity peptide receptor.
López Ordieres MG; Rodríguez de Lores Arnaiz G
Peptides; 2000 Apr; 21(4):571-6. PubMed ID: 10822114
[TBL] [Abstract][Full Text] [Related]
4. Stimulation by neurotensin of (3H)5-hydroxytryptamine (5HT) release from rat frontal cortex slices.
Héaulme M; Leyris R; Soubrié P; Le Fur G
Neuropeptides; 1998 Oct; 32(5):465-71. PubMed ID: 9845009
[TBL] [Abstract][Full Text] [Related]
5. The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.
Gutnisky A; López Ordieres MG; Rodríguez de Lores Arnaiz G
Neurochem Res; 2016 Jun; 41(6):1274-80. PubMed ID: 26738992
[TBL] [Abstract][Full Text] [Related]
6. Mediation by neurotensin-receptors of effects of neurotensin on self-stimulation of the medial prefrontal cortex.
Fernández R; Sabater R; Sáez JA; Montes R; Alba F; Ferrer JM
Br J Pharmacol; 1996 Sep; 119(2):299-302. PubMed ID: 8886412
[TBL] [Abstract][Full Text] [Related]
7. Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KCl versus electrical depolarization.
Heaulme M; Leyris R; Le Fur G; Soubrie P
Neuropharmacology; 1997 Oct; 36(10):1447-54. PubMed ID: 9423933
[TBL] [Abstract][Full Text] [Related]
8. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
Croci T; Landi M; Gully D; Maffrand JP; Le Fur G; Manara L
Br J Pharmacol; 1997 Apr; 120(7):1312-8. PubMed ID: 9105707
[TBL] [Abstract][Full Text] [Related]
9. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
10. Characterization of K(+)-dependent and K(+)-independent p-nitrophenylphosphatase activity of synaptosomes.
Guerra Marichal M; Rodríguez del Castillo A; Martín Vasallo P; Battaner Arias E
Neurochem Res; 1993 Jul; 18(7):751-8. PubMed ID: 8396213
[TBL] [Abstract][Full Text] [Related]
11. Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.
Gully D; Lespy L; Canton M; Rostène W; Kitabgi P; Le Fur G; Maffrand JP
Life Sci; 1996; 58(8):665-74. PubMed ID: 8594316
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin decreases high affinity [3H]-ouabain binding to cerebral cortex membranes.
Rosin C; Ordieres MG; Arnaiz GR
Regul Pept; 2011 Dec; 172(1-3):35-40. PubMed ID: 21896291
[TBL] [Abstract][Full Text] [Related]
13. Effect of neurotensin on synaptosomal membrane ATPase and p-NPPase activities.
López Ordieres MG; Rodríguez de Lores Arnaiz G
Ann N Y Acad Sci; 1997 Nov; 834():548-51. PubMed ID: 9405859
[No Abstract] [Full Text] [Related]
14. Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692.
Lépée-Lorgeoux I; Betancur C; Souazé F; Rostène W; Bérod A; Pélaprat D
J Neurosci Res; 2000 May; 60(3):362-9. PubMed ID: 10797539
[TBL] [Abstract][Full Text] [Related]
15. High-affinity neurotensin receptor is involved in phosphoinositide hydrolysis stimulation by carbachol in neonatal rat brain.
Pereyra-Alfonso S; López Ordieres MG; del V Armanino M; de Lores Arnaiz GR
Brain Res Dev Brain Res; 2005 Feb; 154(2):247-54. PubMed ID: 15707678
[TBL] [Abstract][Full Text] [Related]
16. Effect of the nonpeptide neurotensin antagonist, SR 48692, and two enantiomeric analogs, SR 48527 and SR 49711, on neurotensin binding and contractile responses in guinea pig ileum and colon.
Labbé-Jullié C; Deschaintres S; Gully D; Le Fur G; Kitabgi P
J Pharmacol Exp Ther; 1994 Oct; 271(1):267-76. PubMed ID: 7965724
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of K(+)-p-nitrophenyl phosphatase stimulation by a brain soluble fraction.
Rodríguez de Lores Arnaiz G
Neurochem Res; 1997 Feb; 22(2):215-9. PubMed ID: 9016848
[TBL] [Abstract][Full Text] [Related]
19. In vivo regulation of neurotensin receptors following long-term pharmacological blockade with a specific receptor antagonist.
Azzi M; Boudin H; Mahmudi N; Pélaprat D; Rostène W; Bérod A
Brain Res Mol Brain Res; 1996 Dec; 42(2):213-21. PubMed ID: 9013776
[TBL] [Abstract][Full Text] [Related]
20. Neurotensin inhibits background K+ channels and facilitates glutamatergic transmission in rat spinal cord dorsal horn.
Kadiri N; Rodeau JL; Schlichter R; Hugel S
Eur J Neurosci; 2011 Oct; 34(8):1230-40. PubMed ID: 21936876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
